Literature DB >> 26667841

Network of Surface-Displayed Glycolytic Enzymes in Mycoplasma pneumoniae and Their Interactions with Human Plasminogen.

Anne Gründel1, Melanie Pfeiffer1, Enno Jacobs1, Roger Dumke2.   

Abstract

In different bacteria, primarily cytosolic and metabolic proteins are characterized as surface localized and interacting with different host factors. These moonlighting proteins include glycolytic enzymes, and it has been hypothesized that they influence the virulence of pathogenic species. The presence of surface-displayed glycolytic enzymes and their interaction with human plasminogen as an important host factor were investigated in the genome-reduced and cell wall-less microorganism Mycoplasma pneumoniae, a common agent of respiratory tract infections of humans. After successful expression of 19 glycolytic enzymes and production of polyclonal antisera, the localization of proteins in the mycoplasma cell was characterized using fractionation of total proteins, colony blot, mild proteolysis and immunofluorescence of M. pneumoniae cells. Eight glycolytic enzymes, pyruvate dehydrogenases A to C (PdhA-C), glyceraldehyde-3-phosphate dehydrogenase (GapA), lactate dehydrogenase (Ldh), phosphoglycerate mutase (Pgm), pyruvate kinase (Pyk), and transketolase (Tkt), were confirmed as surface expressed and all are able to interact with plasminogen. Plasminogen bound to recombinant proteins PdhB, GapA, and Pyk was converted to plasmin in the presence of urokinase plasminogen activator and plasmin-specific substrate d-valyl-leucyl-lysine-p-nitroanilide dihydrochloride. Furthermore, human fibrinogen was degraded by the complex of plasminogen and recombinant protein PdhB or Pgm. In addition, surface-displayed proteins (except PdhC) bind to human lung epithelial cells, and the interaction was reduced significantly by preincubation of cells with antiplasminogen. Our results suggest that plasminogen binding and activation by different surface-localized glycolytic enzymes of M. pneumoniae may play a role in successful and long-term colonization of the human respiratory tract.
Copyright © 2016, American Society for Microbiology. All Rights Reserved.

Entities:  

Mesh:

Substances:

Year:  2015        PMID: 26667841      PMCID: PMC4771348          DOI: 10.1128/IAI.01071-15

Source DB:  PubMed          Journal:  Infect Immun        ISSN: 0019-9567            Impact factor:   3.441


  54 in total

1.  Defining the mycoplasma 'cytoskeleton': the protein composition of the Triton X-100 insoluble fraction of the bacterium Mycoplasma pneumoniae determined by 2-D gel electrophoresis and mass spectrometry.

Authors:  J T Regula; G Boguth; A Görg; J Hegermann; F Mayer; R Frank; R Herrmann
Journal:  Microbiology       Date:  2001-04       Impact factor: 2.777

2.  Multiple-mutation reaction: a method for simultaneous introduction of multiple mutations into the glpK gene of Mycoplasma pneumoniae.

Authors:  Claudine Hames; Sven Halbedel; Oliver Schilling; Jörg Stülke
Journal:  Appl Environ Microbiol       Date:  2005-07       Impact factor: 4.792

3.  Terminal organelle development in the cell wall-less bacterium Mycoplasma pneumoniae.

Authors:  Benjamin M Hasselbring; Jarrat L Jordan; Robert W Krause; Duncan C Krause
Journal:  Proc Natl Acad Sci U S A       Date:  2006-10-24       Impact factor: 11.205

Review 4.  Exploitation of plasmin(ogen) by bacterial pathogens of veterinary significance.

Authors:  Benjamin B A Raymond; Steven Djordjevic
Journal:  Vet Microbiol       Date:  2015-04-17       Impact factor: 3.293

5.  Candida albicans binds human plasminogen: identification of eight plasminogen-binding proteins.

Authors:  Jonathan D Crowe; Isla K Sievwright; Gillian C Auld; Norma R Moore; Neil A R Gow; Nuala A Booth
Journal:  Mol Microbiol       Date:  2003-03       Impact factor: 3.501

Review 6.  Pathogenesis of extrapulmonary manifestations of Mycoplasma pneumoniae infection with special reference to pneumonia.

Authors:  Mitsuo Narita
Journal:  J Infect Chemother       Date:  2010-02-27       Impact factor: 2.211

7.  MSG1, a surface-localised protein of Mycoplasma suis is involved in the adhesion to erythrocytes.

Authors:  Ludwig E Hoelzle; Katharina Hoelzle; Marianne Helbling; Heike Aupperle; Heinz A Schoon; Mathias Ritzmann; Karl Heinritzi; Kathrin M Felder; Max M Wittenbrink
Journal:  Microbes Infect       Date:  2007-01-20       Impact factor: 2.700

8.  ADP-ribosylating and vacuolating cytotoxin of Mycoplasma pneumoniae represents unique virulence determinant among bacterial pathogens.

Authors:  T R Kannan; Joel B Baseman
Journal:  Proc Natl Acad Sci U S A       Date:  2006-04-14       Impact factor: 11.205

9.  A major surface protein on group A streptococci is a glyceraldehyde-3-phosphate-dehydrogenase with multiple binding activity.

Authors:  V Pancholi; V A Fischetti
Journal:  J Exp Med       Date:  1992-08-01       Impact factor: 14.307

10.  Candida albicans uses the surface protein Gpm1 to attach to human endothelial cells and to keratinocytes via the adhesive protein vitronectin.

Authors:  Crisanto M Lopez; Reinhard Wallich; Kristian Riesbeck; Christine Skerka; Peter F Zipfel
Journal:  PLoS One       Date:  2014-03-13       Impact factor: 3.240

View more
  16 in total

Review 1.  Mycoplasma pneumoniae from the Respiratory Tract and Beyond.

Authors:  Ken B Waites; Li Xiao; Yang Liu; Mitchell F Balish; T Prescott Atkinson
Journal:  Clin Microbiol Rev       Date:  2017-07       Impact factor: 26.132

2.  Comparative Genomics of Mycoplasma bovis Strains Reveals That Decreased Virulence with Increasing Passages Might Correlate with Potential Virulence-Related Factors.

Authors:  Muhammad A Rasheed; Jingjing Qi; Xifang Zhu; He Chenfei; Harish Menghwar; Farhan A Khan; Gang Zhao; Muhammad Zubair; Changmin Hu; Yingyu Chen; Huanchun Chen; Aizhen Guo
Journal:  Front Cell Infect Microbiol       Date:  2017-05-11       Impact factor: 5.293

3.  Comparative proteomics of two Mycoplasma hyopneumoniae strains and Mycoplasma flocculare identified potential porcine enzootic pneumonia determinants.

Authors:  Jéssica Andrade Paes; Lais Del Prá Netto Machado; Fernanda Munhoz Dos Anjos Leal; Sofia Nóbrega De Moraes; Hercules Moura; John R Barr; Henrique Bunselmeyer Ferreira
Journal:  Virulence       Date:  2018       Impact factor: 5.882

4.  Characterization of Mycoplasma gallisepticum pyruvate dehydrogenase alpha and beta subunits and their roles in cytoadherence.

Authors:  Jingjing Qi; Fanqing Zhang; Yu Wang; Ting Liu; Lei Tan; Shaohui Wang; Mingxing Tian; Tao Li; Xiaolan Wang; Chan Ding; Shengqing Yu
Journal:  PLoS One       Date:  2018-12-10       Impact factor: 3.240

Review 5.  Novel Candidates for Vaccine Development Against Mycoplasma Capricolum Subspecies Capripneumoniae (Mccp)-Current Knowledge and Future Prospects.

Authors:  Mohd Iqbal Yatoo; Oveas Raffiq Parray; Riyaz Ahmed Bhat; Qurat Un Nazir; Abrar Ul Haq; Hamid Ullah Malik; Mujeeb Ur Rehman Fazilli; Arumugam Gopalakrishnan; Shah Tauseef Bashir; Ruchi Tiwari; Sandip Kumar Khurana; Wanpen Chaicumpa; Kuldeep Dhama
Journal:  Vaccines (Basel)       Date:  2019-07-23

Review 6.  Glomerular Deposition of Nephritis-Associated Plasmin Receptor (NAPlr) and Related Plasmin Activity: Key Diagnostic Biomarkers of Bacterial Infection-related Glomerulonephritis.

Authors:  Takahiro Uchida; Takashi Oda
Journal:  Int J Mol Sci       Date:  2020-04-08       Impact factor: 5.923

Review 7.  Infection strategies of mycoplasmas: Unraveling the panoply of virulence factors.

Authors:  Chen Yiwen; Wu Yueyue; Qin Lianmei; Zhu Cuiming; You Xiaoxing
Journal:  Virulence       Date:  2021-12       Impact factor: 5.882

8.  Glyceraldehyde-3-phosphate dehydrogenase (GAPDH) moonlights as an adhesin in Mycoplasma hyorhinis adhesion to epithelial cells as well as a plasminogen receptor mediating extracellular matrix degradation.

Authors:  Jia Wang; Yao Li; Longji Pan; Jun Li; Yanfei Yu; Beibei Liu; Muhammad Zubair; Yanna Wei; Bala Pillay; Ademola Olufolahan Olaniran; Thamsanqa E Chiliza; Guoqing Shao; Zhixin Feng; Qiyan Xiong
Journal:  Vet Res       Date:  2021-06-03       Impact factor: 3.683

9.  Elongation factor Tu is a multifunctional and processed moonlighting protein.

Authors:  Michael Widjaja; Kate Louise Harvey; Lisa Hagemann; Iain James Berry; Veronica Maria Jarocki; Benjamin Bernard Armando Raymond; Jessica Leigh Tacchi; Anne Gründel; Joel Ricky Steele; Matthew Paul Padula; Ian George Charles; Roger Dumke; Steven Philip Djordjevic
Journal:  Sci Rep       Date:  2017-09-11       Impact factor: 4.379

10.  Pathogenic Analysis of the Bronchoalveolar Lavage Fluid Samples With Pediatric Refractory Mycoplasma pneumoniae Pneumonia.

Authors:  Fei Zhao; Jinrong Liu; Di Xiao; Liyong Liu; Jie Gong; Juan Xu; Huimin Li; Shunying Zhao; Jianzhong Zhang
Journal:  Front Cell Infect Microbiol       Date:  2020-10-28       Impact factor: 5.293

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.